BridgeMD
New treatment option for Healthy Adult Participants
Official title A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function
ClinicalTrials.gov ID: NCT07715149
What this study is testing
What is D-2570?
D-2570 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for healthy adult participants.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a single-center, non-randomized, open-label, parallel-group study. It will test D-2570 in people with liver problems and in people with healthy livers, to see how the drug moves through the body and whether it is safe.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Voluntarily participate in this study and sign the written informed consent form after full informed consent, and agree to comply with the procedures...
- Aged 18 to 70 years.
- Both males and females are eligible.
- Male participants must weigh no less than 50 kg, and female participants must weigh no less than 45 kg.
- Participants with normal hepatic function must have adequate hematologic, renal, and hepatic function.
You likely can't join if
- Have undergone any prior surgery that may affect drug absorption, distribution, metabolism, or excretion, which, in the opinion of the investigator...
- Are female and currently lactating, or have a positive serum pregnancy test result at screening or during the study period.
- Have a known history of drug or substance abuse, or test positive for drugs of abuse on the urine drug screen.
- Have participated in another treatment clinical trial within 3 months prior to screening, or are currently participating in another clinical trial...
- Have received a live vaccine within 2 months prior to study drug administration, or intend to receive a live vaccine during the study period.
- Have any other condition or finding that, in the opinion of the investigator, would make the participant unsuitable for participation in this study.
See the full eligibility criteria
- Voluntarily participate in this study and sign the written informed consent form after full informed consent, and agree to comply with the procedures specified in the study protocol.
- Aged 18 to 70 years.
- Both males and females are eligible.
- Male participants must weigh no less than 50 kg, and female participants must weigh no less than 45 kg.
- Participants with normal hepatic function must have adequate hematologic, renal, and hepatic function.
- Have no plan to reproduce or donate sperm/eggs from screening until 30 days after the last dose of study drug, and agree to either completely abstain from sexual intercourse or use effective contraceptive measures from...
- Have undergone any prior surgery that may affect drug absorption, distribution, metabolism, or excretion, which, in the opinion of the investigator, would make the participant unsuitable for enrollment.
- Are female and currently lactating, or have a positive serum pregnancy test result at screening or during the study period.
- Have a known history of drug or substance abuse, or test positive for drugs of abuse on the urine drug screen.
- Have participated in another treatment clinical trial within 3 months prior to screening, or are currently participating in another clinical trial (participants who withdraw from a prior trial before treatment, i.e...
- Have received a live vaccine within 2 months prior to study drug administration, or intend to receive a live vaccine during the study period.
- Have any other condition or finding that, in the opinion of the investigator, would make the participant unsuitable for participation in this study.
The study team makes the final eligibility decision.
Where it's taking place
- Bengbu, Anhui, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bengbu, Anhui, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.